These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 550123)

  • 21. Sex-dependent induction of hepatic enzymes for mutagenic activation of a tryptophan pyrolysate component, 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]-indole, by feeding in mice.
    Degawa M; Kojima M; Hishinuma T; Hashimoto Y
    Cancer Res; 1985 Jan; 45(1):96-102. PubMed ID: 3880668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive genetic hazard predictions from short-term tests have proved false for results in mammalian spermatogonia with all environmental chemicals so far tested.
    Russell WL
    Prog Clin Biol Res; 1986; 209B():67-74. PubMed ID: 3092243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. X chromosome transmission ratio distortion in Cftr +/- intercross-derived mice.
    Haston CK; Humes DG; Lafleur M
    BMC Genet; 2007 May; 8():23. PubMed ID: 17506901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SWR: an inbred strain suitable for generating transgenic mice.
    Osman GE; Jacobson DP; Li SW; Hood LE; Liggitt HD; Ladiges WC
    Lab Anim Sci; 1997 Apr; 47(2):167-71. PubMed ID: 9150496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic transfer of the wobbler gene to a C57BL/6J x NZB hybrid stock: natural history of the motor neuron disease and response to CNTF and BDNF cotreatment.
    Ishiyama T; Klinkosz B; Pioro EP; Mitsumoto H
    Exp Neurol; 1997 Nov; 148(1):247-55. PubMed ID: 9398466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mutagenic action of cadmium chloride in mammals].
    Kozachenko VI; Pashin IuV; Soboleva LS; Sal'nikova LE
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1987; (11):102-5. PubMed ID: 3435731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutagenic activity of 2-amino-N6-hydroxyadenine in the mouse spot test.
    Neuhäuser-Klaus A
    Mutat Res; 1991 Aug; 253(1):109-14. PubMed ID: 1714539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose and effect of methyl-2-benzimidazolylcarbamate in the "mammalian spot test", an in vivo method for the detection of genetic alterations in somatic cells of mice.
    Fahrig R; Seiler JP
    Chem Biol Interact; 1979 Jun; 26(1):115-20. PubMed ID: 466741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the mouse spot test in chemical mutagenesis: interpretation of past data and recommendations for future work.
    Russell LB; Selby PB; von Halle E; Sheridan W; Valcovic L
    Mutat Res; 1981 May; 86(3):355-79. PubMed ID: 7029265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative studies on the metabolism of isoniazid and isoniazid hydroazones in the dog.
    Peters JH; Hayes VE
    Arch Int Pharmacodyn Ther; 1966 Feb; 159(2):328-39. PubMed ID: 5916738
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of metabolism in the hepatotoxicity of isoniazid and iproniazid.
    Timbrell JA
    Drug Metab Rev; 1979; 10(1):125-47. PubMed ID: 393481
    [No Abstract]   [Full Text] [Related]  

  • 33. N1-sulfato-N2-isonicotinylhydrazine. A potential metabolite of isoniazid.
    Peters JH
    J Med Chem; 1969 Jul; 12(4):702-3. PubMed ID: 4978367
    [No Abstract]   [Full Text] [Related]  

  • 34. Somatic cells as indicators of germinal mutations in the mouse.
    Russell LB
    Environ Health Perspect; 1978 Jun; 24():113-6. PubMed ID: 17539138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mutagenic effect of caprolactam in the spot test with (T x HT) F1 mouse embryos.
    Neuhäuser-Klaus A; Lehmacher W
    Mutat Res; 1989 Nov; 224(3):369-71. PubMed ID: 2811928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic fate of hydrazines and hydrazides.
    Colvin LB
    J Pharm Sci; 1969 Dec; 58(12):1433-43. PubMed ID: 4390910
    [No Abstract]   [Full Text] [Related]  

  • 37. Metabolic studies on the possible mode of action of isoniazid tumorigenicity.
    Bhide SV; Maru GB; Mate NB; Menon M; Gangadharan P
    J Cancer Res Clin Oncol; 1981; 99(1-2):153-66. PubMed ID: 6166614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proceedings: A correlated study of isoniazid mutagenesis in mammals and man in 13 laboratories sponsored by the Bundesministerium fur Forschung und Technologie. Concluding remarks.
    Röhrborn G
    Mutat Res; 1975 Aug; 29(2):259-60. PubMed ID: 1186754
    [No Abstract]   [Full Text] [Related]  

  • 39. Specific receptor for hydrazine: mapping the in situ release of hydrazine in live cells and in an in vitro enzymatic assay.
    Ali F; A AH; Taye N; Mogare DG; Chattopadhyay S; Das A
    Chem Commun (Camb); 2016 May; 52(36):6166-9. PubMed ID: 27075169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammalian spot test with moxnidazole, a 5-nitroimidazole.
    Lang R
    Experientia; 1978 Apr; 34(4):500-1. PubMed ID: 565299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.